News
Viral Vector Manufacturing Facility (VVMF) and Cell Therapies enters strategic collaboration
Viral Vector Manufacturing Facility Pty. Ltd. (VVMF) and Cell Therapies Pty Ltd. have co-signed a memorandum of understanding (MoU) to explore strategic collaboration opportunities aimed…
Viral Vector Manufacturing Facility (VVMF) at Bio International Conference 2025
Viral Vector Manufacturing Facility Pty Ltd (VVMF) announces its participation at the Bio International Conference 2025, June 16-19 2025, at the Boston Convention & Exhibition…
Viral Vector Manufacturing Facility (VVMF) at BIO KOREA 2025
Viral Vector Manufacturing Facility Pty Ltd (VVMF) is set to participate in BIO KOREA 2025, May 7-9 2025, bringing its expertise in viral vector manufacturing…
Diversity Disclosure 2023-2024
Viral Vector Manufacturing Facility Pty. Ltd. (“VVMF”, “the Company”) has adopted a Diversity Policy. This Policy requires disclosure regarding: The VVMF Board of Directors (“Board”)…
VVMF announces appointment of the Board
The Viral Vector Manufacturing Facility Pty Ltd (VVMF) is delighted to announce the following appointments to the Board. Sue MacLeman: VVMF Board Chair and Non-Executive…
VVMF announces the appointment of Mr Stephen Thompson as the inaugural Chief Executive Officer
The Viral Vector Manufacturing Facility Pty Ltd (VVMF) Board is delighted to announce the appointment of Mr. Stephen Thompson as the inaugural Chief Executive Officer…